Celiac Disease Treatment Global Market Report 2025
상품코드:1760500
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
셀리악병 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 9.6%의 연평균 성장률(CAGR)로 9억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 전 세계 셀리악병의 유병률 증가, 인식 및 진단율 향상, 새로운 치료법의 임상시험 진행, 무글루텐 대체품에 대한 수요 증가, 희귀 질환에 대한 규제 당국의 지원책, 의료비 지출 증가 등 여러 가지 요인에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 새로운 비식이 요법의 채택, 효소 보충제의 발전, 맞춤형 의료 접근법, 펩타이드 기반 면역요법의 개발, 진단 도구의 개선, 임상시험의 발전 등을 들 수 있습니다.
당뇨병 유병률의 증가는 향후 몇 년 동안 셀리악병 치료 시장의 성장을 견인할 것으로 예상됩니다. 당뇨병은 혈당을 적절히 조절하지 못하는 체질을 특징으로 하는 만성질환입니다. 이러한 당뇨병 유병률의 증가는 당뇨병과 셀리악병 사이에 식단 관리의 필요성이 중복되는 것과 관련이 있습니다. 셀리악병 치료는 글루텐이 없는 식단을 장려하여 당뇨병 환자를 지원하고, 소화기 건강과 영양 흡수를 개선하며, 혈당 조절을 개선하는 데 도움을 줄 수 있습니다. 예를 들어, 2024년 6월 영국 정부 기관인 National Health Service는 2023년 일반 개업의에 등록된 약 361만 5,330명이 비당뇨병성 고혈당증 또는 당뇨병 예비군으로 진단받았다고 보고했으며, 이는 2022년 306만 5,825명에서 18% 증가한 것을 반영합니다. 이처럼 당뇨병 유병률의 증가로 인해 셀리악병 치료 시장이 성장하고 있습니다.
셀리악병 치료 시장의 주요 기업들은 글루텐에 대한 면역 반응을 억제하고, 치료 순응도를 높이며, 제한적인 글루텐 제거 식단에 대한 대안을 제공하기 위해 저분자 약물과 같은 혁신적인 경구용 치료제 개발을 우선시하고 있습니다. 저분자 치료제는 질병을 유발하는 단백질이나 효소를 표적으로 삼아 세포에 침투할 수 있는 작은 크기의 약물입니다. 예를 들어, 2025년 2월 미국 생명공학 기업 Immunic Inc.는 내인성 글루카곤 유사 펩타이드-1(GLP-1) 수치를 증가시키는 저분자 치료제 IMU-856을 발표했습니다. 이 치료제는 체강 장벽의 완전성을 개선하고, 영양 흡수를 증가시키며, 증상을 완화하는 역할을 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 셀리악병 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 셀리악병 치료 시장 : 성장률 분석
세계의 셀리악병 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 셀리악병 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 셀리악병 치료 전체 시장(TAM)
제6장 시장 세분화
세계의 셀리악병 치료 시장 : 치료 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
비타민·미네랄
글루텐 분해 효소
대증요법
기타
세계의 셀리악병 치료 시장 : 증상별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
복부 팽만
설사
식욕 부진
팽만감
장내 가스
피로감
세계의 셀리악병 치료 시장 : 진단별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
혈청학적 검사
유전자 검사
생검
세계의 셀리악병 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
연구 센터
클리닉
기타
세계의 셀리악병 치료 시장 : 비타민·미네랄 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
철분 보충제
칼슘 보충제
비타민 D
비타민 B12
종합비타민
세계의 셀리악병 치료 시장 : 글루텐 분해 효소 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
엔도펩티다제
엑소펩티다제
복합 효소 제제
세계의 셀리악병 치료 시장 : 대증요법 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
지사제
항우울제
항염증제
면역억제제
세계의 셀리악병 치료 시장 : 기타 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
프로바이오틱스
면역요법
줄기세포 치료
실험적 치료법
제7장 지역별·국가별 분석
세계의 셀리악병 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 셀리악병 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
셀리악병 치료 시장 : 경쟁 구도
셀리악병 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Novartis AG
Takeda Pharmaceuticals Company Ltd.
Amgen Inc.
General Mills Inc.
Viatris Inc.
Teva Pharmaceutical Inc.
Nestle Health Science
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Zydus Pharmaceuticals Inc.
Glenmark Pharmaceuticals Company Ltd.
West-Ward Pharmaceuticals Company Ltd
Innovate Biopharmaceutical
Acto Biosciences
ImmunogenX
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
셀리악병 치료 시장 2029년 : 새로운 기회를 제공하는 국가
셀리악병 치료 시장 2029년 : 새로운 기회를 제공하는 부문
셀리악병 치료 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Celiac disease treatment focuses on managing the autoimmune reaction to gluten, which damages the small intestine and impairs nutrient absorption. The primary approach is a strict gluten-free diet, which eliminates foods and products containing wheat, barley, rye, and other gluten-containing grains. This treatment reduces symptoms, heals the small intestine lining, and prevents long-term health complications.
The main types of treatment for celiac disease include vitamins and minerals, gluten-degrading enzymes, symptomatic treatments, and other approaches. Vitamins and minerals are essential micronutrients that support key bodily functions, such as immune response, energy production, and bone health. Enzyme therapies address symptoms such as distension, diarrhea, anorexia, bloating, gas, and fatigue. Diagnostic methods for celiac disease include serological tests, genetic testing, and intestinal biopsy. These treatments and diagnostic services are provided through various distribution channels, including hospitals, research centers, clinics, and others.
The Business Research Company that provides celiac disease treatment market statistics, including the celiac disease treatment industry global market size, regional shares, competitors with the celiac disease treatment market share, detailed celiac disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the celiac disease treatment industry. This celiac disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The celiac disease treatment market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to several factors, including the rising prevalence of celiac disease, increased awareness and diagnosis rates, a growing demand for non-dietary treatment options, a strong pipeline of innovative therapies, supportive regulatory initiatives, and higher investment from pharmaceutical companies.
The celiac disease treatment market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth during the forecast period can be attributed to several factors, including the rising global prevalence of celiac disease, increasing awareness and diagnosis rates, ongoing clinical trials for novel treatments, growing demand for gluten-free alternatives, supportive regulatory initiatives for orphan diseases, and rising healthcare expenditure. Key trends in the forecast period include the adoption of novel non-dietary therapies, advancements in enzyme supplements, personalized medicine approaches, the development of peptide-based immunotherapies, improvements in diagnostic tools, and progress in clinical trials.
The growing prevalence of diabetes is anticipated to drive the expansion of the celiac disease treatment market in the coming years. Diabetes is a chronic condition characterized by the body's inability to properly regulate blood glucose levels. This rise in diabetes prevalence is linked to overlapping dietary management needs between diabetes and celiac disease, as both require careful regulation of food intake to manage symptoms and prevent complications. Celiac disease treatments support individuals with diabetes by promoting a gluten-free diet, which enhances digestive health and nutrient absorption, aiding in improved blood sugar control. For instance, in June 2024, the National Health Service, a UK-based government agency, reported that approximately 3,615,330 individuals registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% increase from 3,065,825 cases in 2022. Thus, the increasing prevalence of diabetes is boosting the celiac disease treatment market.
Leading companies in the celiac disease treatment market are prioritizing the development of innovative oral therapies, such as small molecule drugs, to block immune responses to gluten, enhance treatment adherence, and provide alternatives to restrictive gluten-free diets. Small molecule therapies are compact drugs capable of penetrating cells to target proteins or enzymes that cause disease. For example, in February 2025, Immunic Inc., a US-based biotech firm, introduced IMU-856, a small molecule therapy that elevates endogenous glucagon-like peptide-1 (GLP-1) levels. This treatment improves the integrity of the intestinal barrier in patients with celiac disease, enhances nutrient absorption, and reduces symptoms-all without suppressing immune function.
In October 2022, Takeda Pharmaceutical Company Limited, a pharmaceutical company based in Japan, formed a partnership with Zedira GmbH and Dr. Falk Pharma to develop TAK-227 (ZED1227), an oral treatment for celiac disease. This therapy is designed to target intestinal inflammation and promote mucosal healing, representing a promising new option for patients. Zedira GmbH is a German biotech firm specializing in therapies for celiac disease and other transglutaminase-related conditions. Dr. Falk Pharma, also based in Germany, focuses on pharmaceutical solutions for gastrointestinal disorders.
Major players in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestle Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX.
North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in celiac disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the celiac disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The celiac disease treatment market consists of sales of gluten-free food products, vitamin D, Vitamin B12, and folic acid supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Celiac Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on celiac disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for celiac disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The celiac disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Vitamins And Minerals; Gluten Degrading Enzymes; Symptomatic Treatment; Other Treatments
2) By Enzyme Type: Distension; Diarrhoea; Anorexia; Bloating; Gas; Fatigue
3) By Diagnosis: Serological Tests; Genetic Testing; Biopsy
4) By Distribution Channel: Hospitals; Research Centres; Clinics; Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements; Calcium Supplements; Vitamin D; Vitamin B12; Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases; Exopeptidases; Combination Enzyme Formulations
3. Celiac Disease Treatment Market Trends And Strategies
4. Celiac Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Celiac Disease Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Celiac Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Celiac Disease Treatment Market Growth Rate Analysis
5.4. Global Celiac Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Celiac Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Celiac Disease Treatment Total Addressable Market (TAM)
6. Celiac Disease Treatment Market Segmentation
6.1. Global Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vitamins And Minerals
Gluten Degrading Enzymes
Symptomatic Treatment
Other Treatments
6.2. Global Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Distension
Diarrhea
Anorexia
Bloating
Gas
Fatigue
6.3. Global Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serological Tests
Genetic Testing
Biopsy
6.4. Global Celiac Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Centers
Clinics
Other Distribution Channels
6.5. Global Celiac Disease Treatment Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iron Supplements
Calcium Supplements
Vitamin D
Vitamin B12
Multivitamins
6.6. Global Celiac Disease Treatment Market, Sub-Segmentation Of Gluten Degrading Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endopeptidases
Exopeptidases
Combination Enzyme Formulations
6.7. Global Celiac Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antidiarrheal Medications
Antidepressants
Anti-inflammatory Drugs
Immunosuppressive Agents
6.8. Global Celiac Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Probiotics
Immunotherapy
Stem Cell Therapy
Experimental Therapies
7. Celiac Disease Treatment Market Regional And Country Analysis
7.1. Global Celiac Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Celiac Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
